Fig. 1 (abstract P-276).From: Abstracts from the 25th European Society for Animal Cell Technology Meeting: Cell Technologies for Innovative TherapiesExpression of Trastuzumab (a) and Trastuzumab-IFNα2b (b) from bicistronic strategy (BC) and tricistronic strategy (TRI) with CHO-S and HEK293 cells. Relative specific productivity units are used for comparing the different strategies. c Antigen binding analysis of Trastuzumab and Trastuzumab-IFNα2b. d Antiproliferative activity of Trastuzumab and Trastuzumab-IFNα2b on Sk-br-3 cellsBack to article page